Fig. 2From: Empagliflozin improves insulin sensitivity in patients with recent acute coronary syndrome and newly detected dysglycaemiaChanges in plasma glucose levels and HbA1c from baseline to after seven months on study drug. Legend: HbA1c: glycated haemoglobin A1cBack to article page